« Back to Record
Loibl, S., Lee, S. C., Turri, S., Urban, P., Kümmel, S., Steger, G., Gombos, A., Lux, M., Piccart-Gebhart, M., Von Minckwitz, G., Baselga, J., de la Peña, L., Loi, S., Nekljudova, V., Zardavas, D., Michiels, S., Denkert, C., Rezai, M., Bermejo, B., & Untch, M. (2017). Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). European journal of cancer, 85, 133-145. doi:10.1016/j.ejca.2017.08.020
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/259051



